Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call... (Business Wire) +++ SENSUS HEALTHCARE Aktie +3,91%

INTEGRA LIFESCIENCES Aktie

 >INTEGRA LIFE Aktienkurs 
10.8 EUR    (Tradegate)
Ask: 10.9 EUR / 1700 Stück
Bid: 10.7 EUR / 700 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
INTEGRA LIFE Aktie über LYNX handeln
>INTEGRA LIFE Performance
1 Woche: +2,9%
1 Monat: +5,9%
3 Monate: -26,5%
6 Monate: -56,6%
1 Jahr: -62,8%
laufendes Jahr: -49,1%
>INTEGRA LIFESCIENCES Aktie
Name:  INTEGRA LIFESCIENCES
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US4579852082 / 897013
Symbol/ Ticker:  IL3 (Frankfurt) / IART (NASDAQ)
Kürzel:  FRA:IL3, ETR:IL3, IL3:GR, NASDAQ:IART
Index:  -
Webseite:  https://www.integralife.c..
Marktkapitalisierung:  795.29 Mio. EUR
Umsatz:  1379.48 Mio. EUR
EBITDA:  249.52 Mio. EUR
Gewinn je Aktie:  -0.32 EUR
Schulden:  1714.63 Mio. EUR
Liquide Mittel:  203.06 Mio. EUR
Umsatz-/ Gewinnwachstum:  5.91% / -171.78%
KGV/ KGV lG:  - / 5.4
KUV/ KBV/ PEG:  0.57 / 0.57 / 0.67
Gewinnm./ Eigenkapitalr.:  -1.78% / -1.85%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  INTEGRA LIFESCIENCES, INTEGRA LIFE, INTEGRA LIFESCIENCE
Letzte Datenerhebung:  24.07.25
>INTEGRA LIFE Eigentümer
Aktien: 77.71 Mio. St.
f.h. Aktien: 61.78 Mio. St.
Insider Eigner: 14.23%
Instit. Eigner: 96.62%
>INTEGRA LIFE Peer Group

 
14.07.25 - 22:39
 Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025 (GlobeNewswire EN)
 
PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2025 financial results on Thursday, July 31, 2025, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET....
02.07.25 - 22:12
 Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry (GlobeNewswire EN)
 
PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first patient in the Acclarent AERA Pediatric Registry, a prospective, multi-center observational registry evaluating the real-world use of the AERA Eustachian Tube Balloon Dilation System in children....
30.05.25 - 16:00
 Is the Options Market Predicting a Spike in Integra LifeSciences Stock? (Zacks)
 
Investors need to pay close attention to Integra LifeSciences stock based on the movements in the options market lately....
26.05.25 - 16:03
 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART (PR Newswire)
 
NEW YORK, May 26, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.......
20.05.25 - 15:03
 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART (PR Newswire)
 
NEW YORK, May 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.......
20.05.25 - 11:33
 IART Investors Have Opportunity to Join Integra LifeSciences Holdings Corporation Fraud Investigation with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, May 20, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ: IART) for violations of the......
07.05.25 - 00:45
 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART (PR Newswire)
 
NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.......
05.05.25 - 20:00
 Integra LifeSciences plans $390M-$400M Q2 revenue amid compliance initiatives (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.05.25 - 15:15
 Integra LifeSciences (IART) Q1 Earnings Miss Estimates (Zacks)
 
Integra (IART) delivered earnings and revenue surprises of -4.65% and 0.13%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...
05.05.25 - 12:36
 Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.41 misses by $0.02, revenue of $382.65M beats by $1.48M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.05.25 - 12:33
 Integra LifeSciences Reports First Quarter 2025 Financial Results (GlobeNewswire EN)
 
PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2025....
02.05.25 - 20:12
 Integra LifeSciences Holdings Corporation Q1 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.04.25 - 22:33
 Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 (GlobeNewswire EN)
 
PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial results on Monday, May 5, 2025, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET....
13.03.25 - 22:03
 Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference (GlobeNewswire EN)
 
PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer will present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 17, 2025 at 10:00am ET....
25.02.25 - 14:30
 Integra LifeSciences (IART) Surpasses Q4 Earnings Estimates (Zacks)
 
Integra (IART) delivered earnings and revenue surprises of 14.12% and 0.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...
25.02.25 - 12:06
 Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.97 beats by $0.12, revenue of $442.6M misses by $2.55M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
25.02.25 - 12:03
 Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance (GlobeNewswire EN)
 
PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2024....
24.02.25 - 18:42
 Integra LifeSciences Holdings Corporation Q4 2024 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.02.25 - 14:33
 Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025 (GlobeNewswire EN)
 
PRINCETON, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET....
14.01.25 - 14:33
 Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs) (GlobeNewswire EN)
 
New global medical education platform offers digital tools to keep HCPs at the forefront of medical knowledge New global medical education platform offers digital tools to keep HCPs at the forefront of medical knowledge...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Im strengen Sinne des Wortes hat es nie eine wirkliche Demokratie gegeben und wird es niemals geben. - Jean-Jacques Rousseau
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!